Cited by 1,091Schizophrenia research and treatmentGenetic Associations and EpidemiologyNeurotransmitter Receptor Influence on Behavior

Gene expression elucidates functional impact of polygenic risk for schizophrenia

Open access
Fromer, Menachem, Roussos, Panos, Sieberts, Solveig K, Johnson, Jessica S, Kavanagh, David H, Perumal, Thanneer M, Ruderfer, Douglas M, Oh, Edwin C +50 more·2016·Nature Neuroscience

Published version of a preprint

Abstract

Over 100 genetic loci harbor schizophrenia-associated variants, yet how these variants confer liability is uncertain. The CommonMind Consortium sequenced RNA from dorsolateral prefrontal cortex of people with schizophrenia (N = 258) and control subjects (N = 279), creating a resource of gene expression and its genetic regulation. Using this resource, ∼20% of schizophrenia loci have variants that could contribute to altered gene expression and liability. In five loci, only a single gene was involved: FURIN, TSNARE1, CNTN4, CLCN3 or SNAP91. Altering expression of FURIN, TSNARE1 or CNTN4 changed neurodevelopment in zebrafish; knockdown of FURIN in human neural progenitor cells yielded abnormal migration. Of 693 genes showing significant case-versus-control differential expression, their fold changes were ≤ 1.33, and an independent cohort yielded similar results. Gene co-expression implicates a network relevant for schizophrenia. Our findings show that schizophrenia is polygenic and highlight the utility of this resource for mechanistic interpretations of genetic liability for brain diseases.

Integrity signals

Registry

Crossref · 10.1038/nn.4399

Cites

155 of 155 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

0 of 84 cited sources checked · 0 supported · 0 flagged

  • Findingown data

    Only five genes in the MHC locus were ranked highly by Sherlock and passed concordance evaluation: C4A, HCG17, VARS2, HLA-DMB, and BRD2.

    “Nevertheless, only five genes in this locus were ranked highly by Sherlock and passed evaluation for concordance of associations (Supplementary data file 2): C4A, HCG17, VARS2, HLA-DMB, and BRD2.”
    Quote in the paperSubstantial claim
  • Findingown data

    When CMC eQTLs at FDR ≤ 5% were intersected with HBCC eQTLs at FDR ≤ 20%, 93% showed the same direction of allelic effect.

    “Moreover, concordance of the direction of allelic effect was high, with 93% of eQTL showing the same direction of effect when intersecting CMC eQTL (FDR ≤ 5%) with even a liberally defined set of HBCC eQTL (FDR ≤ 20%).”
    Quote in the paperSubstantial claim
  • Findingown data

    Schizophrenia cases carried more common variant alleles previously associated with schizophrenia risk than controls, with P = 1.6 × 10−8.

    “As expected3, SCZ cases inherited an increased number of common variant alleles previously associated with SCZ risk (P = 1.6 × 10−8, Supplementary Fig. 1D).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [3] Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014). source

      Not checked in the free run.

  • Findingown data

    Of the 108 previously reported schizophrenia GWAS loci, 73 contain cis-eQTL SNPs for one or more genes at FDR ≤ 5%.

    “Of the 108 SCZ GWAS loci previously reported3, 73 harbor cis-eQTL SNPs for one or more genes (FDR ≤ 5%).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [3] Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014). source

      Not checked in the free run.

  • Findingown data

    Overexpression of TSNARE1 in zebrafish embryos significantly decreased head size by 9.5%, P < 0.001.

    “Relative to control embryos, overexpression of TSNARE1 or CNTN4 resulted in a significant decrease in head size, 9.5% (P < 0.001) and 3.5% (P = 0.018), respectively, while SNAP91 or CLCN3 showed no statistically significant effect (Fig. 3A, B).”
    Quote in the paperSubstantial claim
  • May combine two claims. 158
  • The quote only partly states this claim. 1
  • Classified as probably not a substantial claim. 103
  • May combine two claims.

    Findingown data

    Suppression of furin_a in zebrafish led to a 24% decrease in head size, and this was replicated in CRISPR/Cas9 mutants and with a second splice-blocking morpholino.

    “Suppression of furin_a led to a 24% decrease in head size (Fig. 3A, B); this observation was replicated in CRISPR/Cas9 mutants (Supplementary Fig. 8) and in embryos injected with a second sbMO targeting exon 5 (data not shown)”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Overexpression of CNTN4 and suppression of furin_a decreased proliferating PH3-positive cells by 9.8%, P = 0.003, and 29.8%, P < 0.001, respectively.

    “Overexpression of CNTN4 and suppression of furin_a led to a 9.8% (P = 0.003) and a 29.8% (P < 0.001) decrease, respectively, in proliferating cells marked by phospho-histone3 (PH3), and overexpression of TSNARE1 led to a 9.5% increase (P = 0.018) in proliferating cells (N = 20 per experiment; Fig. 3C, D).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Among 19 GWAS loci with schizophrenia-associated cis-eQTLs, eight implicated only a single gene: FURIN down-regulated, TSNARE1 up-regulated, CNTN4 up-regulated, CLCN3 up-regulated, SNAP91 up-regulated, ENSG00000259946 up-regulated, ENSG00000253553 down-regulated, and the ENST00000528555 isoform of SNX19 down-regulated.

    “Of the 19 GWAS loci harboring SCZ-associated cis-eQTLs, eight involved only a single gene (i.e., no additional gene with relaxed adjusted Sherlock p < 0.5): furin (FURIN, down-regulated by risk allele), t-SNARE domain containing 1 (TSNARE1, up), contactin 4 (CNTN4, up), voltage-sensitive chloride channel 3 (CLCN3, up), synaptosomal-associated protein of 91 kDa (SNAP91, up), ENSG00000259946 (up),”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In ROS/MAP, the top GWAS SNP was also a significant eQTL with the same direction of effect as CMC for FURIN, CLCN3, and SNAP91; TSNARE1 and CNTN4 had the same direction but did not reach significance.

    “The most significant GWAS SNP was also a significant eQTL with the same direction of effect as in CMC for FURIN (rs4702: P = 1 × 10−6), CLCN3 (rs10520163: P = 9 × 10−6), and SNAP91 (rs3798869: P = 3 × 10−4); TSNARE1 (rs4129585: P = 0.057) and CNTN4 (rs17194490: P = 0.07) also had alleles in the same direction of effect as in CMC but did not reach significance.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The CMC sample contains most eQTLs reported in the literature and also finds many genes with previously undetected eQTLs.

    “In addition to containing the vast majority of eQTL found in the literature, the CMC sample finds a substantial number of genes with previously undetected eQTL (Table 1).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Trans-eQTLs were not enriched for brain enhancers, but were enriched in genic regions and depleted in intergenic regions, especially when restricted to trans-eQTLs at least 10 Mb from the gene.

    “Enrichment of trans-eQTLs with brain enhancers was not observed (data not shown), though enrichment in genic regions and depletion in intergenic regions was observed, particularly when restricting to trans eQTL ≥ 10 Mb from the gene location.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Isoform-level eQTL analysis identified nine genes in eight GWAS loci, with all but three already found in the gene-level analysis.

    “Repeating the analyses using isoform-level eQTLs (isoQTL) identified nine genes in eight GWAS loci, with all but three genes already identified in the gene-level analysis (Supplementary data file 2).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The data supported 45,453 significant trans-eQTLs at FDR ≤ 5%, of which 20,288 were also cis-eQTL SNPs for local genes and 34% predicted expression of more than one distant gene.

    “Nevertheless, the data supported 45,453 significant trans-eQTL at FDR ≤ 5%, of which 20,288 were also cis- eQTL SNPs for local genes, and 34% predicted expression of more than one distant gene.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Cis-eQTLs were enriched for enhancer sequences present in brain tissues, with the strongest enrichment in DLPFC enhancers.

    “Cis-eQTLs were enriched for enhancer sequences present in brain tissues (Kolmogorov-Smirnov (KS) test versus non-brain: D = 1, P = 4.5 × 10−6), and the strongest enrichment is observed in DLPFC enhancers (Z = 9.5) (Fig. 1C).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    There were 8,427 eGenes at FDR ≤ 5%, corresponding to 18 eGenes discovered per sample, matching a GTEx prediction.

    “There were 8,427 eGenes at FDR ≤ 5%, or 18 eGenes discovered per sample, consistent with a prediction from GTEx.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Because of linkage disequilibrium, many eQTLs for a gene were highly correlated, and 32.8% of eQTL SNPs predicted expression of more than one gene.

    “Many eQTLs for the same gene were highly correlated, due to linkage disequilibrium, and 32.8% of eQTL SNPs (“eSNPs”) predict expression of more than one gene.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The proportion of CMC trans-eQTLs replicating in HBCC was 18.6%, and the proportion of HBCC trans-eQTLs replicating in CMC was 29.7%.

    “The proportion of trans eQTL in CMC that replicate in HBCC is 18.6% (both FDR ≤ 5%). The proportion of HBCC trans eQTL that replicate in CMC is 29.7%.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingcitation

    Cis-eSNPs were enriched in genic elements and non-coding RNAs, especially within 100 kb of transcription start and end sites, and were depleted in intergenic regions.

    “Cis-eSNPs were enriched within genic elements and non-coding RNAs, particularly within 100 kb of the transcription start and end sites12, and depleted in intergenic regions (Fig. 1A, B).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [12] Veyrieras, J.B. et al. High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet. 4, e1000214 (2008). source

      Not checked in the free run.

  • May combine two claims. The quote only partly states this claim.

    Findingown data

    CMC eQTLs captured most eQTLs found in other independent brain samples, with replication π1 values of 0.98 for GTEx v6 and 0.70-0.93 for several microarray datasets.

    “Considering microarray-based eQTLs from the Harvard Brain Bank 15, BrainCloud16, NIH17, and the UK Brain Expression Consortium (UKBEC)18, we estimated π1 to be 0.75, 0.70, 0.79, and 0.93, respectively, indicating that our results captured most eQTLs found in other independent samples.”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites [15] Zhang, B. et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell 153, 707–720 (2013). source

      Not checked in the free run.

    • cites [16] Colantuoni, C. et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 478, 519–523 (2011). source

      Not checked in the free run.

    • cites [17] Gibbs, J.R. et al. Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet. 6, e1000952 (2010). source

      Not checked in the free run.

  • May combine two claims.

    Findingown data

    The cis-eQTL model found 2,154,331 significant cis-eQTLs at FDR ≤ 5%, covering 13,137 of 16,423 genes, or 80%.

    “The model identified 2,154,331 significant cis-eQTLs, (i.e., within 1 Mb of a gene) at a false discovery rate (FDR) ≤ 5%, for 13,137 (80%) of 16,423 genes.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Overexpression of SNAP91 or CLCN3 had no statistically significant effect on zebrafish head size.

    “Relative to control embryos, overexpression of TSNARE1 or CNTN4 resulted in a significant decrease in head size, 9.5% (P < 0.001) and 3.5% (P = 0.018), respectively, while SNAP91 or CLCN3 showed no statistically significant effect (Fig. 3A, B).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Across the genome, assuming 10,000 genes, the median number of cases and controls needed for 80% power is approximately 28,500, which exceeds the size of any available dataset.

    “Genome-wide, the median number of cases and controls needed to obtain 80% power assuming 10,000 genes is ~28,500, well beyond any available dataset (Fig. 7B,C).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The CMC data include a comprehensive compilation of gene expression patterns and an intensive evaluation of eQTLs across the genome.

    “They include a comprehensive compilation of gene expression patterns, together with intensive evaluation of eQTLs across the genome.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Mixture analysis of P values for 16,423 genes suggested that approximately 44% of genes are perturbed in schizophrenia, and the excess of low P values disappeared when case and control labels were permuted.

    “Analysis of the distribution of P values for the 16,423 genes was tested for a mixture of disease-associated and null distributions for 25 cases and 25 controls and suggests that approximately 44% of genes are perturbed in SCZ; this excess of low P values disappears when case and control labels are permuted.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The differentially expressed genes had modest fold changes, with a mean of 1.09 and a range of 1.03 to 1.33.

    “All had modest fold changes (Fig. 5B), with a mean of 1.09 and range 1.03–1.33 (inverting down-regulated expression ratios).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The M2c module was associated with differential expression, OR = 2.3 and P = 1 × 10−13, and was enriched for GWAS loci, rare CNV, and rare nonsynonymous variants.

    “Of these, however, only one (M2c) shows association with differential expression (OR = 2.3, P = 1 × 10−13) and multiple prior genetic associations with SCZ; the latter encompasses genes in GWAS loci (FE [fold-enrichment] = 1.36, P = 0.04), rare CNV (FE = 1.52, P = 0.051), and rare nonsynonymous variants (FE = 1.18, P = 2 × 10−4) (Supplementary table 3).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In an independent HBCC cohort, differential expression test statistics correlated with CMC for 480 of 693 differentially expressed genes, r = 0.58, and across all 10,928 common genes, r = 0.28.

    “there was high correlation of test statistics for differential expression in CMC compared to HBCC for the differentially expressed genes also present in the HBCC data (480 of 693), Pearson correlation r = 0.58 (P < 10−16); the correlation remains high (r = 0.28, P < 10−16) across all 10,928 genes common to both platforms after QC (Fig. 5C).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingcitation

    Among the top 100 differentially expressed genes were GABRA5 and CALB1, genes previously reported as differentially expressed in cortical tissue from schizophrenia patients, suggesting GABAergic interneuron dysfunction.

    “Also included among the top 100 differentially expressed genes are the alpha 5 subunit of the GABA A receptor (GABRA5) and calbindin (CALB1), genes previously reported as differentially expressed in cortical tissue from schizophrenia patients, suggesting GABAergic interneuron dysfunction45.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [45] Sakai, T. et al. Changes in density of calcium-binding-protein-immunoreactive GABAergic neurons in prefrontal cortex in schizophrenia and bipolar disorder. Neuropathology 28, 143–150 (2008). source

      Not checked in the free run.

  • May combine two claims.

    Findingown data

    Without a fold-change threshold, 693 genes were differentially expressed between schizophrenia cases and controls at FDR ≤ 5%, with 332 up-regulated and 361 down-regulated.

    “Without imposing a threshold on the magnitude of fold change in mean expression between SCZ and controls, we find 693 genes to be differentially expressed after correction for multiple testing (FDR ≤ 5%), 332 up-regulated and 361 down-regulated (Fig. 5A, Supplementary data file 3).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    A subnetwork of approximately 1,400 genes involved in synaptic transmission is significantly altered in schizophrenia and shows strong enrichment for schizophrenia genetic risk signal.

    “Finally, we identified a subnetwork of ~1400 genes sub-serving functions related to synaptic transmission that is significantly perturbed in SCZ and is highly enriched for SCZ genetic signal.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    The control co-expression network contained 35 modules with 30 to 1,900 genes each, plus about 3,600 unclustered genes.

    “The co-expression network generated from the controls consisted of 35 modules each containing between 30 and 1,900 genes, along with ~3,600 unclustered genes (Supplementary data file 5).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The 239 differentially expressed isoforms came from 223 genes, were enriched for overlap with the 693 differentially expressed genes, P = 2 × 10−131, and 136 were differentially expressed at both gene and isoform levels.

    “These isoforms derive from 223 genes, which are enriched, as expected, for overlap with the 693 differentially expressed genes (P = 2 × 10−131, Fisher’s exact test), and 136 are differentially expressed at both the gene and isoform levels (Supplementary Fig. 11).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The M2c module showed a loss of density in schizophrenia cases, permutation Z = −1.79 and one-tailed P = 0.037, but no loss of connectivity.

    “The M2c module exhibits a loss of density in the SCZ cases (permutation Z = −1.79, one-tailed P = 0.037, Fig. 6B) but no loss of connectivity.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    After filtering, 43,817 isoforms from 12,329 genes remained for analysis.

    “After filtering, a total of 43,817 isoforms of 12,329 genes remained for analysis.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    In CMC eQTL data, the only overlap between SCZ association and eQTLs was for MLH1, with up-regulation predicted to be associated with genetic risk variation, but this overlap was below genome-wide significance (Sherlock P = 6 × 10−5, Bonferroni corrected P = 0.69).

    “In our CMC eQTL data, there is only overlap between the SCZ association and eQTLs for MLH1, with up-regulation of expression predicted to be associated with the genetic risk variation; however, this overlap is below the genome-wide threshold, Sherlock P = 6 × 10−5, Bonferroni corrected P = 0.69.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    For the 13 genes tested, the Pearson correlation between qPCR expression ratios and voom-normalized log(CPM) was above 0.5 for 9 genes, between 0.1 and 0.3 for 3 genes, and negative for HIVEP2.

    “The Pearson correlation between these expression ratios and the voom-normalized log(CPM) levels for the same subjects was greater than 0.5 for 9 of the 13 genes (Supplementary Fig. 3A); for an additional 3 genes, it was between 0.1 and 0.3, and only for one gene (HIVEP2) was the correlation negative.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Findingown data

    The enhancer-overlap analysis used 13,137 cis- and 851 trans-eSNPs, defined as the most significantly associated SNP per gene.

    “We tested for enrichment of significant eQTLs at FDR ≤ 5%, using as an index eQTL SNP (eSNP) the most significantly associated SNP per gene (“max-eQTL”), which resulted in 13,137 and 851 cis- and trans-eSNPs, respectively.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    There were 3,355,111 significant cis-isoQTLs at FDR ≤ 5%, representing 27,691 isoforms of 10,779 genes.

    “Using similar techniques to derive isoform expression quantitative trait loci (isoQTLs), we identified 3,355,111 significant cis-isoQTLs at FDR ≤ 5%, representing 27,691 isoforms of 10,779 genes.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    In the CMC cohort, differential expression t-statistics for the 172 youngest cases and controls (mean age 45.5, range 20-60) correlated with those from the full cohort at Pearson r = 0.62, and this correlation was not significantly lower than that for 100 random subsets of the same size (mean r = 0.69, P = 0.28).

    “for the 172 cases and controls whose age of death was youngest (mean age 45.5, range 20–60), the t-statistics for differential expression were highly correlated with those from the full cohort (Pearson r = 0.62), yet somewhat lower (though not significantly, P = 0.28) than for 100 random subsets of the same size (mean r = 0.69, standard deviation = 0.13)”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    58% of isoQTLs were cis-eQTLs for the parent gene at FDR ≤ 5%, and 71% of cis-eQTLs for genes with at least one represented isoform were isoQTLs at FDR ≤ 5%.

    “IsoQTLs and gene-level eQTLs overlapped substantially; 58% of isoQTLs were cis-eQTLs for the parent gene at FDR ≤ 5%; conversely, 71% of cis-eQTLs for genes with at least one represented isoform were isoQTLs at FDR ≤ 5%.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    Omitting the Sherlock exclusion for SNPs not in 1000 Genomes affected 49,612 (4.4%) of the 1,127,447 eSNPs also found in PGC SCZ2 GWAS data.

    “We also slightly modified the Sherlock source code, omitting the exclusion criterion for SNPs (and genes whose expression is associated with those SNPs) that could not be found in the 1000 Genomes data, which encompassed only 49,612 [4.4%] of the 1,127,447 eSNPs also found in the PGC SCZ2 GWAS data 3.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [3] Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014). source

      Not checked in the free run.

  • May combine two claims.

    Findingown data

    Permutation of disease status showed that overlaps between case-derived and control-derived eQTL were similar to what is expected for two homogeneous sets of these sample sizes, with limited evidence for condition-specific eQTL.

    “However, permutation of disease status indicated that the overlaps between case-derived eQTL and control-derived eQTL were similar to the amount expected for two homogeneous sets of these sample sizes, and there was limited evidence for condition-specific eQTL.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    There were 39,414 significant trans-isoQTLs, representing 964 isoforms from 836 genes, and 61% of these were also trans-eQTLs for the same gene.

    “At the isoform level, there were 39,414 significant trans-isoQTLs, representing 964 isoforms (836 genes), of which 61% were also trans-eQTLs for the same gene.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Findingown data

    After preprocessing and quality control, the HBCC replication microarray cohort contained 131 schizophrenia and 176 control DLPFC samples (plus 43 bipolar disorder and 88 major depressive disorder samples used only for eQTL derivation).

    “After preprocessing and quality control to check for outliers and sex mismatches, there remained 131 SCZ and 176 control samples (as well as 43 BP and 88 MDD samples, where these latter samples were used only for eQTL derivation).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Haloperidol signature genes were significantly enriched among CMC schizophrenia differentially expressed genes (P = 1 × 10−9), whereas the clozapine signature was not (P = 0.29).

    “Significant enrichment was observed (Supplementary Table 2A) for the haloperidol signatures, but not the clozapine signature (P = 1 × 10−9 and 0.29, respectively).”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Findingown data

    Using a nominal P ≤ 0.01 cutoff, haloperidol and clozapine treatment signatures yielded human-orthologous gene sets of 237 and 31 genes, respectively.

    “we used a nominal P ≤ 0.01 cutoff to identify signatures for haloperidol and clozapine treatment, which resulted in human-orthologous gene sets of size 237 and 31, respectively.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingown data

    Gene sets appearing in three or more or two or more rodent studies did not reach statistical significance but showed a trend for overlap (P = 0.084 and 0.071, respectively).

    “Sets of genes that appeared in 3 or more studies, or 2 or more studies, also did not reach statistical significance but did show a trend for overlap (P = 0.084 and 0.071, respectively).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingown data

    The gene set curation yielded 2,902 sets in total: 1,938 from Gene Ontology, 824 from Reactome, and 140 gene families.

    “This procedure yielded 2,902 gene sets in total: 1,938 sets from GO, 824 from Reactome, and 140 gene families.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    In rodent drug signatures, none were significantly enriched after Bonferroni correction (Pbonferroni > 0.05), but two signatures were significantly less concordant than expected by chance after multiple test correction (Pbonferroni = 0.01 and 0.01).

    “using the KS test for enrichment, none of the gene signatures were strictly significant after Bonferroni correction (Pbonferroni > 0.05), though two signatures were significantly less concordant than expected by chance after multiple test correction (Pbonferroni = 0.01 and 0.01, Supplementary Table 2B).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    In the controls-only polygenic risk score analysis, no single gene was significantly associated with PRS after FDR 5% correction, but the P-value distribution was inflated (π1 = 0.22).

    “While no single gene was found to be significantly associated with PRS after correction for multiple testing using an FDR approach (cutoff of 5%), there was inflation of the P value distribution101 consistent with a non-uniform distribution (π1 = 0.22).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [101] Storey, J.D. & Tibshirani, R. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. USA 100, 9440–9445 (2003). source

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Findingown data

    In permuted sets, network statistics also showed large differences with module size.

    “In the permuted sets, we again observed large differences of the network statistics with module size.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The haloperidol signature was significantly less concordant in direction than expected by chance (35 of 237 genes, one-sided P < 1 × 10−4), while the clozapine signature showed significant concordance (22 of 31 genes, one-sided P = 0.013).

    “We found the haloperidol signature significantly less concordant than expected by chance (35 out of 237 genes concordant, one-sided P < 1 × 10−4), while the clozapine signature showed significant concordance, despite the lack of enrichment in the previous test (22 of 31 genes concordant, one-sided P = 0.013).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    A set of 693 genes was significantly differentially expressed at FDR ≤ 5% between schizophrenia cases and controls and was used for genetic overlap tests.

    “we tested the associations for enrichment in a gene set consisting of the 693 genes found to be significantly (FDR ≤ 5%) differentially expressed between SCZ cases and controls (up- or down-regulated).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In CMC, Pitt samples make up 26% of all schizophrenia cases and controls, and 63% of the 20-60 age group samples are from Pitt.

    “while Pitt samples compose 26% of all SCZ cases and controls in CMC, 63% of the aged 20–60 CMC samples are from Pitt”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    In independent rodent datasets, drug-impacted genes overlapped with disease-associated genes, but the directions of effect on expression were opposite.

    “Using the independent rodent datasets, we found overall similar results as that in the monkeys, with some overlaps of genes impacted by drugs and associated with disease, but with opposite directions of effect on gene expression.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Findingown data

    After conditioning on DLPFC expression, de novo mutations included 103 loss-of-function mutations in 101 genes and 638 nonsynonymous mutations across 605 genes.

    “Conditioning on DLPFC expression, there were 103 loss-of-function mutations in 101 genes, and a total of 638 nonsynonymous mutations across 605 genes.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Among differentially expressed DLPFC genes, 236 genes had one or more singleton loss-of-function variants and 440 genes had singleton damaging nonsynonymous variants.

    “Looking only at differentially expressed DLPFC genes, there were 236 genes with one or more singleton loss-of-function variants and a total of 440 genes harboring singleton damaging nonsynonymous variants.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    After conditioning on DLPFC expression, the 12 schizophrenia-associated CNV regions spanned 127 genes.

    “After conditioning on DLPFC expression, the 12 regions spanned 127 genes.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    In the HBCC replication cohort, 2,288 genes were differentially expressed at FDR 5% between schizophrenia cases and controls, with 1,166 up-regulated and 1,122 down-regulated.

    “We performed differential expression analysis with adjustment for covariates, using linear regression models in limma and identified 2,288 differentially expressed genes at FDR 5%, among which 1,166 and 1,122 were up-regulated and down-regulated in SCZ, respectively.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The most represented rodent drug signature genes showed a non-significant trend toward enrichment (p = 0.061), and one gene, ATRX, was significant in the CMC DLPFC data at FDR ≤ 5% (FDR = 4.5%).

    “A one-sided test of enrichment for these “most represented” genes showed a non-significant trend towards enrichment (p = 0.061), with one gene from the signature significant in the CMC DLPFC data at FDR ≤ 5% (ATRX, FDR = 4.5%).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    A set of 21 genes appeared in four or more rodent drug signatures; 16 of these had orthologs in the normalized data, and 8 showed concordant direction in all four studies.

    “we identified a set of 21 genes that appeared in 4 or more of the gene signatures; 16 of these genes were represented by orthologs in our normalized data, and 8 showed concordant direction in all 4 studies.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    After intersecting with DLPFC-expressed genes, 87 of the 108 schizophrenia GWAS loci spanned one or more genes, encompassing 489 genes.

    “After intersecting with DLPFC-expressed genes from this paper, there were 87 loci spanning one or more genes, encompassing a total of 489 genes.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingnone given

    The CommonMind Consortium is the largest existing collection of collaborating brain banks and includes over 1,150 samples.

    “The CMC is the largest existing collection of collaborating brain banks and includes over 1,150 samples.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Altering expression of FURIN, TSNARE1, or CNTN4 changes neurodevelopment in zebrafish.

    “Altering expression of FURIN, TSNARE1, or CNTN4 changes neurodevelopment in zebrafish”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingcitation

    Cis-eSNPs are enriched within genic elements and non-coding RNAs, particularly within 100 kb of transcription start and end sites, and depleted in intergenic regions.

    “Cis-eSNPs were enriched within genic elements and non-coding RNAs, particularly within 100 kb of the transcription start and end sites12, and depleted in intergenic regions (Fig. 1A, B).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [12] Veyrieras, J.B. et al. High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet. 4, e1000214 (2008). source

      Not checked in the free run.

  • May combine two claims.

    Findingown data

    Trans-eQTLs were not enriched with brain enhancers, but were enriched in genic regions and depleted in intergenic regions, particularly for trans-eQTLs at least 10 Mb from the gene location.

    “Enrichment of trans-eQTLs with brain enhancers was not observed (data not shown), though enrichment in genic regions and depletion in intergenic regions was observed, particularly when restricting to trans eQTL ≥ 10 Mb from the gene location.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    eQTLs for FURIN, CLCN3, and SNAP91 replicated in ROS/MAP with the same direction of effect; TSNARE1 and CNTN4 had alleles in the same direction but did not reach significance.

    “The most significant GWAS SNP was also a significant eQTL with the same direction of effect as in CMC for FURIN (rs4702: P = 1 × 10−6), CLCN3 (rs10520163: P = 9 × 10−6), and SNAP91 (rs3798869: P = 3 × 10−4); TSNARE1 (rs4129585: P = 0.057) and CNTN4 (rs17194490: P = 0.07) also had alleles in the same direction of effect as in CMC but did not reach significance.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [26] De Jager, P.L. et al. Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat. Neurosci. 17, 1156–1163 (2014). source

      Not checked in the free run.

  • May combine two claims.

    Findingown data

    The proportion of trans-eQTLs in CommonMind Consortium that replicate in HBCC is 18.6%, and the proportion of HBCC trans-eQTLs that replicate in CommonMind Consortium is 29.7%.

    “The proportion of trans eQTL in CMC that replicate in HBCC is 18.6% (both FDR ≤ 5%). The proportion of HBCC trans eQTL that replicate in CMC is 29.7%.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Replication was lower for a meta-analysis of mixed brain regions (π1 = 0.62) and for blood eQTLs (π1 = 0.54).

    “Replication was somewhat lower for a recent meta-analysis that included a mix of several distinct brain regions19 (π1 = 0.62), and for eQTLs detected in blood (π1 = 0.54)20.”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [19] Kim, Y. et al. A meta-analysis of gene expression quantitative trait loci in brain. Transl. Psychiatry 4, e459 (2014). source

      Not checked in the free run.

    • cites [20] Wright, F.A. et al. Heritability and genomics of gene expression in peripheral blood. Nat. Genet. 46, 430–437 (2014). source

      Not checked in the free run.

  • May combine two claims.

    Findingown data

    The data supported 45,453 significant trans-eQTLs at FDR ≤ 5%, of which 20,288 were also cis-eQTL SNPs for local genes, and 34% predicted expression of more than one distant gene.

    “Nevertheless, the data supported 45,453 significant trans-eQTL at FDR ≤ 5%, of which 20,288 were also cis- eQTL SNPs for local genes, and 34% predicted expression of more than one distant gene.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingown data

    After normalization, 16,423 genes were expressed at levels sufficient for analysis, of which 14,222 were protein coding.

    “Following data normalization, 16,423 genes (based on Ensembl models) were expressed at levels sufficient for analysis, of which 14,222 were protein coding.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    CommonMind Consortium eQTLs replicate most eQTLs found in other independent samples, with π1 values of 0.98 for GTEx v6, 0.75 for Harvard Brain Bank, 0.70 for BrainCloud, 0.79 for NIH, 0.93 for UKBEC, and 0.77 for HBCC.

    “GTEx v6 is the largest public dataset of eQTLs from DLPFC tissue (n = 92) assayed by RNA-seq; its replication in CMC is π1 = 0.98.”
    • Also stated in: § Generation of a brain eQTL resource · hedged
      “Considering microarray-based eQTLs from the Harvard Brain Bank 15, BrainCloud16, NIH17, and the UK Brain Expression Consortium (UKBEC)18, we estimated π1 to be 0.75, 0.70, 0.79, and 0.93, respectively”
    • Also stated in: § Generation of a brain eQTL resource · plain
      “We also derived eQTL for 279 DLPFC samples as part of the NIMH Human Brain Collection Core (HBCC) microarray data and found replication π1 = 0.77.”
    Quote in the paperSubstantial claim0 of 4 sources checked
    • cites [15] Zhang, B. et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell 153, 707–720 (2013). source

      Not checked in the free run.

    • cites [16] Colantuoni, C. et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 478, 519–523 (2011). source

      Not checked in the free run.

    • cites [17] Gibbs, J.R. et al. Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet. 6, e1000952 (2010). source

      Not checked in the free run.

    • cites [18] Ramasamy, A. et al. Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat. Neurosci. 17, 1418–1428 (2014). source

      Not checked in the free run.

  • May combine two claims.

    Findingown data

    Isoform-level eQTL analysis identified nine genes in eight GWAS loci, with all but three already identified in the gene-level analysis.

    “Repeating the analyses using isoform-level eQTLs (isoQTL) identified nine genes in eight GWAS loci, with all but three genes already identified in the gene-level analysis (Supplementary data file 2).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Cis-eQTLs are enriched for enhancer sequences present in brain tissues, with the strongest enrichment in DLPFC enhancers.

    “Cis-eQTLs were enriched for enhancer sequences present in brain tissues (Kolmogorov-Smirnov (KS) test versus non-brain: D = 1, P = 4.5 × 10−6), and the strongest enrichment is observed in DLPFC enhancers (Z = 9.5) (Fig. 1C).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [14] GTEx Consortium. Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348, 648–660 (2015).

      Not checked in the free run.

  • May combine two claims.

    Findingown data

    There were 8,427 eGenes at FDR ≤ 5%, or 18 eGenes discovered per sample, consistent with a prediction from GTEx.

    “There were 8,427 eGenes at FDR ≤ 5%, or 18 eGenes discovered per sample, consistent with a prediction from GTEx.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [13] Dunham, I. et al. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74 (2012). source

      Not checked in the free run.

  • May combine two claims.

    Findingown data

    These isoforms derive from 223 genes, are enriched for overlap with the 693 differentially expressed genes (P = 2 × 10−131), and 136 are differentially expressed at both gene and isoform levels.

    “These isoforms derive from 223 genes, which are enriched, as expected, for overlap with the 693 differentially expressed genes (P = 2 × 10−131, Fisher’s exact test), and 136 are differentially expressed at both the gene and isoform levels (Supplementary Fig. 11).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Suppression of furin_a led to a 24% decrease in head size, replicated in CRISPR/Cas9 mutants and with a second splice-blocking morpholino.

    “Suppression of furin_a led to a 24% decrease in head size (Fig. 3A, B); this observation was replicated in CRISPR/Cas9 mutants (Supplementary Fig. 8) and in embryos injected with a second sbMO targeting exon 5 (data not shown)”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    239 isoforms were differentially expressed between schizophrenia cases and controls: 94 up-regulated and 145 down-regulated.

    “We identified 239 isoforms differentially expressed between SCZ cases and controls: 94 up-regulated and 145 down-regulated.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingcitation

    Genes affected by antipsychotics are often the same as those altered in schizophrenia, but the impact of antipsychotic drugs tends to be in the opposite direction of that observed in schizophrenia subjects.

    “Although analyses of experiments performed using either monkeys or rodents indicate that genes whose expression are affected by antipsychotics are often the same as those we find altered in individuals with SCZ, the impact of antipsychotic drugs nevertheless tends to be significantly in the opposite direction of that observed in the SCZ subjects (Supplementary Table 2).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    693 genes were differentially expressed at FDR ≤ 5%, with 332 up-regulated and 361 down-regulated.

    “we find 693 genes to be differentially expressed after correction for multiple testing (FDR ≤ 5%), 332 up-regulated and 361 down-regulated (Fig. 5A, Supplementary data file 3).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The loss of density replicates in the HBCC cohort (Z = −3.02, P = 0.003), indicating that regulatory coordination of genes in this module is disrupted in schizophrenia.

    “The loss of density replicates in the HBCC cohort (Z = −3.02, P = 0.003), indicating that the regulatory coordination of genes in this module is disrupted in SCZ.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Overexpression of TSNARE1 or CNTN4 in zebrafish decreased head size by 9.5% and 3.5%, respectively; SNAP91 or CLCN3 had no statistically significant effect.

    “Relative to control embryos, overexpression of TSNARE1 or CNTN4 resulted in a significant decrease in head size, 9.5% (P < 0.001) and 3.5% (P = 0.018), respectively, while SNAP91 or CLCN3 showed no statistically significant effect (Fig. 3A, B).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    The control co-expression network consisted of 35 modules each containing between 30 and 1,900 genes, along with about 3,600 unclustered genes.

    “The co-expression network generated from the controls consisted of 35 modules each containing between 30 and 1,900 genes, along with ~3,600 unclustered genes (Supplementary data file 5).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    All differentially expressed genes had modest fold changes, with a mean of 1.09 and range 1.03-1.33.

    “All had modest fold changes (Fig. 5B), with a mean of 1.09 and range 1.03–1.33 (inverting down-regulated expression ratios).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Overexpression of CNTN4 and suppression of furin_a decreased proliferating PH3 cells by 9.8% and 29.8%, respectively; overexpression of TSNARE1 increased proliferating cells by 9.5%.

    “Overexpression of CNTN4 and suppression of furin_a led to a 9.8% (P = 0.003) and a 29.8% (P < 0.001) decrease, respectively, in proliferating cells marked by phospho-histone3 (PH3), and overexpression of TSNARE1 led to a 9.5% increase (P = 0.018) in proliferating cells (N = 20 per experiment; Fig. 3C, D).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The M2c module shows association with differential expression (OR = 2.3, P = 1 × 10−13) and multiple prior genetic associations with schizophrenia: GWAS loci (FE = 1.36, P = 0.04), rare CNV (FE = 1.52, P = 0.051), and rare nonsynonymous variants (FE = 1.18, P = 2 × 10−4).

    “only one (M2c) shows association with differential expression (OR = 2.3, P = 1 × 10−13) and multiple prior genetic associations with SCZ; the latter encompasses genes in GWAS loci (FE [fold-enrichment] = 1.36, P = 0.04), rare CNV (FE = 1.52, P = 0.051), and rare nonsynonymous variants (FE = 1.18, P = 2 × 10−4) (Supplementary table 3).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In the independent HBCC sample, correlation of differential expression test statistics was r = 0.58 for 480 of 693 genes and r = 0.28 across all 10,928 common genes.

    “there was high correlation of test statistics for differential expression in CMC compared to HBCC for the differentially expressed genes also present in the HBCC data (480 of 693), Pearson correlation r = 0.58 (P < 10−16); the correlation remains high (r = 0.28, P < 10−16) across all 10,928 genes common to both platforms after QC (Fig. 5C).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingcitation

    The top 100 differentially expressed genes include GABRA5 and CALB1, genes previously reported as differentially expressed in cortical tissue from schizophrenia patients, suggesting GABAergic interneuron dysfunction.

    “Also included among the top 100 differentially expressed genes are the alpha 5 subunit of the GABA A receptor (GABRA5) and calbindin (CALB1), genes previously reported as differentially expressed in cortical tissue from schizophrenia patients, suggesting GABAergic interneuron dysfunction45.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [45] Sakai, T. et al. Changes in density of calcium-binding-protein-immunoreactive GABAergic neurons in prefrontal cortex in schizophrenia and bipolar disorder. Neuropathology 28, 143–150 (2008). source

      Not checked in the free run.

  • May combine two claims.

    Findingown data

    The study identified a subnetwork of about 1,400 genes involved in synaptic transmission that is significantly perturbed in schizophrenia and highly enriched for schizophrenia genetic signal.

    “Finally, we identified a subnetwork of ~1400 genes sub-serving functions related to synaptic transmission that is significantly perturbed in SCZ and is highly enriched for SCZ genetic signal.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Genome-wide, assuming 10,000 genes, the median number of cases and controls needed for 80% power is about 28,500, which exceeds any available dataset.

    “Genome-wide, the median number of cases and controls needed to obtain 80% power assuming 10,000 genes is ~28,500, well beyond any available dataset (Fig. 7B,C).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Analysis of P values suggests approximately 44% of genes are perturbed in schizophrenia; this excess of low P values disappears when case and control labels are permuted.

    “Analysis of the distribution of P values for the 16,423 genes was tested for a mixture of disease-associated and null distributions for 25 cases and 25 controls and suggests that approximately 44% of genes are perturbed in SCZ; this excess of low P values disappears when case and control labels are permuted.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The M2c module exhibits a loss of density in schizophrenia cases (permutation Z = −1.79, one-tailed P = 0.037) but no loss of connectivity.

    “The M2c module exhibits a loss of density in the SCZ cases (permutation Z = −1.79, one-tailed P = 0.037, Fig. 6B) but no loss of connectivity.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Among differentially expressed DLPFC genes, 236 carried at least one singleton loss-of-function variant and 440 carried singleton damaging nonsynonymous variants.

    “Looking only at differentially expressed DLPFC genes, there were 236 genes with one or more singleton loss-of-function variants and a total of 440 genes harboring singleton damaging nonsynonymous variants.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The most-represented rodent genes had a non-significant enrichment trend (p = 0.061); one gene, ATRX, was significant in CMC DLPFC at FDR ≤ 5% (FDR = 4.5%).

    “A one-sided test of enrichment for these “most represented” genes showed a non-significant trend towards enrichment (p = 0.061), with one gene from the signature significant in the CMC DLPFC data at FDR ≤ 5% (ATRX, FDR = 4.5%).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    For isoforms, 39,414 significant trans-isoQTLs were found, covering 964 isoforms from 836 genes; 61% of these were also trans-eQTLs for the same gene.

    “At the isoform level, there were 39,414 significant trans-isoQTLs, representing 964 isoforms (836 genes), of which 61% were also trans-eQTLs for the same gene.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Permutation of disease status showed that the overlap between case-derived and control-derived eQTL was similar to that expected for two homogeneous sets of these sample sizes, providing limited evidence for condition-specific eQTL.

    “However, permutation of disease status indicated that the overlaps between case-derived eQTL and control-derived eQTL were similar to the amount expected for two homogeneous sets of these sample sizes, and there was limited evidence for condition-specific eQTL.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Gene sets present in at least three or at least two rodent studies were not significant but trended toward overlap (P = 0.084 and 0.071, respectively).

    “Sets of genes that appeared in 3 or more studies, or 2 or more studies, also did not reach statistical significance but did show a trend for overlap (P = 0.084 and 0.071, respectively).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Across 1,000 case-control permutations, the mean count of significant genes at FDR ≤ 0.05 was 4.3, far lower than the 693 observed in the sample.

    “Significance was also assessed by permuting case-control status for 1,000 experiments. Of these experiments, the average number of significant genes at FDR ≤ 0.05 was 4.3, well below 693 found in our sample.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    With a nominal P ≤ 0.01 threshold, the haloperidol and clozapine signatures produced human-orthologous sets of 237 and 31 genes, respectively.

    “we used a nominal P ≤ 0.01 cutoff to identify signatures for haloperidol and clozapine treatment, which resulted in human-orthologous gene sets of size 237 and 31, respectively.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    In CMC eQTL data, MLH1 was the sole gene showing overlap with the SCZ association, with up-regulation predicted to be linked to genetic risk variation; this overlap fell below the genome-wide threshold (Sherlock P = 6 × 10^-5, Bonferroni corrected P = 0.69).

    “In our CMC eQTL data, there is only overlap between the SCZ association and eQTLs for MLH1, with up-regulation of expression predicted to be associated with the genetic risk variation; however, this overlap is below the genome-wide threshold, Sherlock P = 6 × 10−5, Bonferroni corrected P = 0.69.”
    Quote in the paperNot a substantial claim
    • The authors state this as an assumption: When a risk gene's expression is altered by genetic variation, the same SNPs should show genetic association with disease.
    • The authors state this as an assumption: If a gene's expression changes mediate disease risk, then its cis- and trans-eQTLs should also associate with the disease.
    • Rests on an assumption: For most SNPs without clear schizophrenia association, selecting the major or minor allele is essentially random and unbiased.
  • May combine two claims.

    Findingown data

    In the HBCC microarray DLPFC cohort, 2,288 genes were differentially expressed at FDR 5% between SCZ cases and controls, with 1,166 up-regulated and 1,122 down-regulated in SCZ.

    “identified 2,288 differentially expressed genes at FDR 5%, among which 1,166 and 1,122 were up-regulated and down-regulated in SCZ, respectively.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Among isoQTLs, 58% were cis-eQTLs for the parent gene at FDR ≤ 5%; among cis-eQTLs for genes with at least one represented isoform, 71% were isoQTLs at FDR ≤ 5%.

    “IsoQTLs and gene-level eQTLs overlapped substantially; 58% of isoQTLs were cis-eQTLs for the parent gene at FDR ≤ 5%; conversely, 71% of cis-eQTLs for genes with at least one represented isoform were isoQTLs at FDR ≤ 5%.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The haloperidol signature showed significant enrichment in the CMC SCZ differential expression test (P = 1 × 10−9), but the clozapine signature did not (P = 0.29).

    “Significant enrichment was observed (Supplementary Table 2A) for the haloperidol signatures, but not the clozapine signature (P = 1 × 10−9 and 0.29, respectively).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingnone given

    In CMC, 26% of schizophrenia cases and controls come from Pitt.

    “while Pitt samples compose 26% of all SCZ cases and controls in CMC”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    A total of 3,355,111 cis-isoQTLs reached FDR ≤ 5%, covering 27,691 isoforms from 10,779 genes.

    “Using similar techniques to derive isoform expression quantitative trait loci (isoQTLs), we identified 3,355,111 significant cis-isoQTLs at FDR ≤ 5%, representing 27,691 isoforms of 10,779 genes.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    For de novo mutations, after restricting to DLPFC expression, 103 loss-of-function mutations fell in 101 genes and 638 nonsynonymous mutations in 605 genes.

    “Conditioning on DLPFC expression, there were 103 loss-of-function mutations in 101 genes, and a total of 638 nonsynonymous mutations across 605 genes.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    For 9 of the 13 genes tested, the Pearson correlation between qPCR expression ratios and voom-normalized log(CPM) levels in the same subjects exceeded 0.5; for 3 additional genes it was between 0.1 and 0.3, and for one gene (HIVEP2) it was negative.

    “The Pearson correlation between these expression ratios and the voom-normalized log(CPM) levels for the same subjects was greater than 0.5 for 9 of the 13 genes (Supplementary Fig. 3A); for an additional 3 genes, it was between 0.1 and 0.3, and only for one gene (HIVEP2) was the correlation negative.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The mRIN statistic distribution is centered near zero and has no extreme negative values.

    “The distribution is centered near zero and has no extreme negative values.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Twenty-one genes occurred in at least four rodent signatures; orthologs for 16 were present in the normalized data, and 8 had concordant direction across all four studies.

    “we identified a set of 21 genes that appeared in 4 or more of the gene signatures; 16 of these genes were represented by orthologs in our normalized data, and 8 showed concordant direction in all 4 studies.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Rodent drug datasets showed some overlap between drug-affected genes and disease-associated genes, but the directions of effect were opposite.

    “Using the independent rodent datasets, we found overall similar results as that in the monkeys, with some overlaps of genes impacted by drugs and associated with disease, but with opposite directions of effect on gene expression.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    Among CMC samples aged 20-60, 63% originated from Pitt.

    “63% of the aged 20–60 CMC samples are from Pitt”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingown data

    Curation produced 2,902 gene sets: 1,938 GO, 824 Reactome, and 140 gene-family sets.

    “This procedure yielded 2,902 gene sets in total: 1,938 sets from GO, 824 from Reactome, and 140 gene families.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Premisecitation

    More than one hundred common genetic variants have been conclusively linked to schizophrenia risk.

    “including rare copy number variants2 and >100 common variants3.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [3] Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014). source

      Not checked in the free run.

  • May combine two claims.

    Premisereasoning

    Findings from prior schizophrenia expression studies are frequently inconsistent and rarely replicated.

    “Results are often inconsistent and there are few replicated findings.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    Over fifty schizophrenia case-control expression studies have been published, often using overlapping samples and mostly at modest scale, with prior RNA sequencing studies examining only five to thirty-one cases.

    “More than 50 gene expression studies of SCZ cases and controls have been reported, often of overlapping samples and mostly of modest scale (prior RNA sequencing studies evaluated only 5–31 cases, Supplementary data file 1).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Supplementary data file 1

      Not checked in the free run.

  • May combine two claims.

    Study design and conductown data

    Known covariates including RIN, library batch, institution, diagnosis, age at death, genetic ancestry, PMI, and sex explained 0.42 of the average variance in gene expression and were used to adjust all analyses.

    “Covariates for RIN, library batch, institution (brain bank), diagnosis, age of death, genetic ancestry, PMI, and sex together explained a substantial fraction (0.42) of the average variance of gene expression, and were thus employed to adjust the data for all analyses.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    CLCN3, SNAP91, and TSNARE1 are direct synaptic components, while CNTN4 and FURIN function in neurodevelopment.

    “CLCN3, SNAP91, and TSNARE1 are direct synaptic components, and CNTN4 and FURIN play roles in neurodevelopment.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    Experimental manipulation of three genes affected neuroanatomical and developmental attributes in model systems, making them strong candidates for further biological investigation.

    “Experimental manipulation of three of these genes had an impact on neuroanatomical and developmental attributes in model systems, making these genes excellent candidates for further biological investigation.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductnone given

    Cases were excluded if they had neuropathology related to Alzheimer's or Parkinson's disease, acute neurological insults immediately before death, or were on ventilators near death.

    “Cases were excluded if they had neuropathology related to Alzheimer’s disease and/or Parkinson’s disease, acute neurological insults (anoxia, strokes, and/or traumatic brain injury) immediately prior to death, or were on ventilators near the time of death.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    Replicable differences in gene expression in schizophrenia point to subtle but broad disruption in transcription, consistent with the polygenic nature of genetic risk.

    “We also detected replicable differences in gene expression in SCZ that point to subtle but broad disruption in transcription, which is consistent with the polygenic nature of genetic risk underlying SCZ.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    The M2c module of about 1,400 genes with synaptic transmission functions is enriched for differential expression, overlaps schizophrenia genetic signal, and has some genes with less dense co-expression in schizophrenia cases.

    “Overall, our results point to the M2c module of ~1400 genes that possess functions related to synaptic transmission as being enriched for differential expression, overlapping SCZ genetic signal, and with some genes having less dense co-expression in SCZ cases.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Study design and conductnone given

    Postmortem tissue from schizophrenia and affective disorder cases was included only if it met DSM-IV diagnostic criteria, as determined by consensus conferences after reviewing medical records, clinical assessments, and family interviews.

    “Postmortem tissue from schizophrenia (SCZ) and bipolar or other affective/mood disorder (AFF) cases were included if they met the appropriate diagnostic DSM-IV criteria, as determined in consensus conferences after review of medical records, direct clinical assessments, and interviews of family members or care providers.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Study design and conductown data

    Age at death and cell type proportions did not explain significant differential expression.

    “An assessment of the impact of age at death or cell type proportions suggests that these variables do not explain significant differential expression (Supplementary Fig. 12).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    The differential expression observed in CMC is smaller than in earlier studies but is consistent with plausible models for average differential expression and the polygenic inheritance of schizophrenia.

    “The differential expression observed here is smaller than that reported in earlier studies (Supplementary data file 1), but it is consistent with plausible models for average differential gene expression and the polygenic inheritance of SCZ (Supplementary Text, “Differential gene expression: expectation, variability, and power analyses”).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premiseown data

    In monkey and rodent experiments, genes affected by antipsychotics often overlap with genes altered in schizophrenia, but the antipsychotic effect tends to be in the opposite direction.

    “Although analyses of experiments performed using either monkeys or rodents indicate that genes whose expression are affected by antipsychotics are often the same as those we find altered in individuals with SCZ, the impact of antipsychotic drugs nevertheless tends to be significantly in the opposite direction of that observed in the SCZ subjects (Supplementary Table 2).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Supplementary Table 2

      Not checked in the free run.

  • May combine two claims.

    Interpretationown data

    The loss of M2c density replicated in the HBCC cohort, Z = −3.02 and P = 0.003, indicating that regulatory coordination of genes in this module is disrupted in schizophrenia.

    “The loss of density replicates in the HBCC cohort (Z = −3.02, P = 0.003), indicating that the regulatory coordination of genes in this module is disrupted in SCZ.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    The genes highlighted by the schizophrenia case-control contrast do not largely trace their differential expression to antipsychotic medications, although they suggest a mechanism for the efficacy of these drugs.

    “Thus, our analyses find that genes highlighted by the contrast of SCZ cases versus control subjects do not largely trace their differential expression to antipsychotic medications, although intriguingly they do suggest a mechanism for the efficacy of these drugs46.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [46] Carboni, L. & Domenici, E. Proteome effects of antipsychotic drugs: learning from preclinical models. Proteomics Clin. Appl. 10, 430–441 (2016). source

      Not checked in the free run.

  • May combine two claims.

    Interpretationcitation

    For a gene whose differential expression is mainly driven by case-control allele frequency differences at an eQTL SNP, the expected fold-change magnitude is on the order of the allele frequency differences, about 1-2%, matching the CMC data.

    “For that gene, the expected magnitude of differential expression fold change will be on the order of the allele frequency differences seen in the recent large Psychiatric Genomic Consortium SCZ genetic association study (~1–2%)3, precisely what is observed in the CMC data.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [3] Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Only karyotypically normal hiPSC lines were used in subsequent studies.

    “Karyotyping analysis was performed by Wicell Cytogenetics (Madison WI); only karyotypically normal lines were used for subsequent studies.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductcitation

    Initial genotyping quality control removed markers with zero alternate alleles, call rate ≤ 0.98, Hardy-Weinberg P < 5 × 10−5, and individuals with genotyping call rate < 0.90.

    “Initial QC was preformed using PLINK 57 to remove markers with: zero alternate alleles, genotyping call rate ≤ 0.98, Hardy-Weinberg P value < 5 × 10−5, and individuals with genotyping call rate < 0.90.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [57] Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductown data

    The hiPSC forebrain NPCs were derived from three controls selected irrespective of their genotype at FURIN-eQTL SNP rs4702; two were heterozygous G/A and one was homozygous risk G/G.

    “These samples were selected irrespective of their genotypes for the FURIN-eQTL SCZ-risk variant at SNP rs4702, with two being heterozygous G/A and the third homozygous risk G/G.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Samples with an RNA Integrity Number below 5.5 were excluded from the study.

    “51 samples with RIN < 5.5 were excluded from the study”
    • Also stated in: § RNA Sample QC · plain
      “Samples were excluded if RIN < 5.5 or genetic information from the sample was inconsistent with subject descriptors such as sex.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductcitation

    Hidden covariates were derived for use in eQTL analyses and included in the normalization and adjustment steps.

    “Next, hidden covariates were derived (for use in eQTL analyses only, as is common practice13). These covariates were then included for adjustment in the normalization and adjustment steps.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [13] Dunham, I. et al. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74 (2012). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductown data

    Ancestry was inferred using clusterGem in GemTools, which found that five dimensions and seven clusters sufficiently described the ancestry space, and 667 subjects were assigned ancestry based on DNA genotypes.

    “Ancestry was determined using clusterGem in GemTools (arXiv:1104.116260,61, http://www.wpic.pitt.edu/wpiccompgen/GemTools/GemTools.htm). Gemtools found that 5 dimensions and 7 clusters were sufficient to describe the ancestry space. Because one sample was missing key phenotypic information, 667 subjects were assigned ancestry based on DNA genotypes.”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites arXiv:1104.116260

      Not checked in the free run.

    • cites [61] Luca, D. et al. On the use of general control samples for genome-wide association studies: genetic matching highlights causal variants. Am. J. Hum. Genet. 82, 453–463 (2008). source

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Study design and conductnone given

    For most analyses, a linear regression of gene expression on disease status plus selected covariates was performed using weighted regression with voom confidence weights.

    “For most analyses, we perform a variant of the following basic linear regression: gene expression~Dx+selected covariates where Dx is the disease status of an individual, the gene expression is given in log(CPM), and weighted regression is performed using the voom confidence weights from above.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductown data

    The entire quality control process yielded 592 high-quality samples for analysis, comprising 258 schizophrenia cases, 279 controls, and 55 affective disorder cases.

    “The entire QC process yielded 592 high-quality samples for analysis (258 SCZ, 279 control individuals, and 55 AFF [47 bipolar disorder, 6 major depressive disorder, and 2 mood disorder, unspecified])”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductown data

    The final covariate model included 12 sample variables (Dx, Institution, Sex, AOD, PMI, RIN, RIN2, and 5 ancestry vectors) and 1 experiment variable (clustered LIB), accounted for 23 df, and had an average r2 of 0.42.

    “The final model, which we call “the covariate model”, included 12 sample variables (Dx [3], Institution [3], Sex [2], AOD, PMI, RIN, RIN2, and 5 ancestry vectors) and 1 experiment variable (clustered LIB [9]), where the number of levels for factor variables is noted here in square brackets. Counting the intercept term, this model accounted for 23 df and yielded an average r2 of 0.42”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Study design and conductown data

    FURIN knockdown was validated by qPCR.

    “FURIN knockdown was validated by qPCR using TaqMan® RNA-to-Ct™ 1-Step Kit (ThermoFisher Scientific – 4392938).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductown data

    RNA-seq outliers were detected by two independent groups, and 10 samples identified as outliers by both groups were eliminated from all subsequent analyses.

    “In total, 10 samples were identified as outliers by both groups and these were eliminated from all subsequent analyses.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S1 (asserted), S4 (based). May combine two claims.

    Study design and conductown data

    DNA and RNA data were verified to come from a single individual by comparing SNP calls from RNA-seq and genotyping arrays; this process identified one sample mix-up and three contaminated samples, which were removed.

    “We ensured DNA and RNA data were from a single individual by making SNP calls from RNA-seq results using samtools and bcftools 0.1.19, using the author-recommended protocol, which includes the “Bayesian inference” option.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductown data

    HBCC eQTL were generated using 279 genetically-inferred Caucasian samples (76 controls, 72 SCZ, 43 BP, 88 MDD) in a manner analogous to CMC, adjusting for diagnosis and 5 ancestry components.

    “Next, eQTL were generated using N = 279 genetically-inferred Caucasian samples (76 controls, 72 SCZ, 43 BP, 88 MDD) in an analogous manner to CMC, adjusting for diagnosis and 5 ancestry components.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Study design and conductown data

    Genes were filtered to retain 16,423 genes with at least 1 CPM in at least 50% of individuals for all subsequent analyses.

    “we filtered out all genes with lower expression in a substantial fraction of the cohort, with 16,423 genes remaining with at least 1 CPM in at least 50% of the individuals; note that only these genes were carried forward into all subsequent analyses.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductown data

    The order of extraction for schizophrenia-affected and control samples was randomized with respect to brain bank, diagnosis, and all other sample characteristics, and Pitt matched pairs were processed in the same batch.

    “The order of extraction for SCZ-affected and control samples was assigned randomly with respect to brain bank, diagnosis, and all other sample characteristics.”
    • Also stated in: § Tissue, RNA and DNA preparation · plain
      “Samples were processed in batches of 12, and the Pitt matched case/control pairs were always processed in the same batch.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductnone given

    Pitt specimens were provided as matched case-control pairs, perfectly matched for sex and as closely as possible for age and race, and members of a pair were always processed together for RNA-seq.

    “Specimens from Pitt were provided as matched case/control pairs. These were perfectly matched for sex, and as closely as possible for age (73% of pairs were matched within 5 years, and 95% within 10 years) and race (71% of pairs were matched for race). Members of a pair were always processed together for RNA-seq.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Study design and conductnone given

    Penn diagnoses were made using DSM-IV criteria through clinical interview by a psychiatrist and review of medical records.

    “Disease diagnoses were made based on DSM-IV criteria and obtained through a clinical interview by psychiatrist and review of medical records.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationown data

    The Allen Human Brain Atlas ISH data suggest that genes identified by differential expression analysis display various degrees of cell-type specificity.

    “The data suggest that genes identified by DE analysis display various degrees of cell-type specificity.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductnone given

    All zebrafish experiments were replicated twice and aggregate data were compiled.

    “All experiments were replicated twice and aggregate data was compiled.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductreasoning

    To avoid population stratification, the first 500 ROS/MAP subjects were randomly selected from self-reported white, non-Hispanic subjects with genome-wide genotype data confirming that ancestry.

    “To avoid population stratification artifacts in the genetic analyses, the first 500 subjects were randomly selected from among those subjects that are self-reported to be of white, non-Hispanic ancestry, and have genome-wide genotype data (N = 1,709 for the entire ROS and MAP studies) that confirm this self-reported ancestry.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning

    The gender-neutral model for X chromosome SNPs was appropriate because gene expression had already been adjusted for gender.

    “The regression modeling was performed for SNPs on the X chromosome in the same manner as for those on the autosomes (i.e., with a dosage scaling between 0 and 2 for both males and females); this gender-neutral model was appropriate here since the gene expression was already adjusted for gender.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Technical validation compared RNA-seq results to qPCR for 13 genes previously reported to be altered in the same brain region in 57 schizophrenia cases and 57 matched controls from the Pitt cohort.

    “For a selected set of 13 genes that had been previously reported to be altered in this same brain region in 57 SCZ cases relative to 57 matched controls among the Pitt cohort (Supplementary Fig. 3), we compared results from RNA-seq to that of qPCR when these quantifications are taken from different tissue samples, although they were taken from the same subject and roughly the same brain region.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductnone given

    Processing order was re-randomized before ribosomal RNA depletion, and samples were processed in batches of eight.

    “Processing order was re-randomized prior to ribosomal RNA (rRNA) depletion, and samples were processed in batches of 8.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    For 85% of analyzed isoforms, the correlation across samples between unique reads per isoform and isoform-level CPM was above 0.2.

    “For 85% of the analyzed isoforms, the correlation across samples between the number of unique reads per isoform, arguably, the most direct measure of relative isoform abundance from RNA-seq, and the isoform-level CPM was above 0.2.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Pitt case-control pairs were batched together in each processing step, including Ribo-Zero depletion, library preparation, and sequencing lane.

    “The Pitt case/control pairs were batched together in each processing step, including Ribo-Zero depletion, sequence library preparation, and sequencing lane.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    NPC experiments used passage-matched populations between passages 9 and 12.

    “NPC experiments were conducted on passage-matched populations, between passages 9 and 12.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductown data

    Cross-validation randomly split the full cohort into an 80% discovery and 20% replication cohort with equal proportions of SCZ cases and controls, repeated 20 times.

    “We performed cross-validation of the differential expression by randomly splitting the full cohort into an 80% “discovery” cohort and 20% “replication” cohort (with equal proportions of SCZ cases and controls into the two parts of the split). This splitting process was repeated 20 times.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductown data

    Samples were retained for downstream analysis only if they had at least 50 million mapped reads and less than 5% rRNA-aligned reads; 15 samples failed these criteria and were discarded.

    “Samples with a minimum of 50 million mapped reads (~25 million paired end reads) and less than 5% rRNA-aligned reads were retained for downstream analysis.”
    • Also stated in: § RNA Library Preparation and Sequencing · plain
      “In the end, a total of 15 samples did not meet these sequencing criteria (see “Sample QC” below) and were discarded.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisenone given

    The CMC eQTL data are substantially larger than existing brain eQTL datasets, which were more limited in power for eQTL discovery.

    “Then, because the data herein are substantially larger than existing brain eQTL datasets that were therefore more limited in power for eQTL discovery, we focused on testing the sensitivity of our eQTL towards recapitulating publicly available eQTL.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductown data

    Three case samples with leukotomies or a history of head injury prior to diagnosis were included, and they were not outliers on any metrics used to evaluate the samples.

    “Three case samples (2 with leukotomies, and 1 with a history of a head injury prior to diagnosis) were included; these were not outliers on any metrics that we used to evaluate our samples”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductown data

    PEER was applied to ROS/MAP gene expression data to account for non-genetic factors such as batch effects, age, gender, and technical artifacts.

    “To account for non-genetic factors such as batch effects, age, gender, and technical artifacts in the gene expression data, PEER70 was applied.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning

    For most SNPs in the genome that are not clearly associated with SCZ, the choice of major or minor allele is essentially random and unbiased.

    “Still, for most SNPs in the genome, those not clearly associated with SCZ, the choice of major or minor allele is essentially random and unbiased.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductreasoning

    The 5 ancestry vectors were included in the eQTL model to control for ancestry differences in SNP allele frequencies.

    “The 5 ancestry vectors were included instead in the eQTL model to control for ancestry differences in SNP allele frequencies.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    All hiPSC and NPC lines were tested monthly with MycoAlert to ensure they remained mycoplasma free.

    “All hiPSC and NPCs in the laboratory are tested monthly using MycoAlert (Lonza) to ensure they remain mycoplasma free.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductown data

    Because of module-size dependency, the authors performed 1,000 permutations of disease status and estimated module-size-dependent null distributions for binned module sizes.

    “Thus, as an alternative, we performed 1,000 permutations of disease status for the final cohort analyzed for co-expression (278 control and 254 schizophrenia samples), followed by generation of gene co-expression networks and estimation of network preservation statistics.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductreasoning

    Enrichment analysis used a combination of gene permutation and subject permutation methods, and the results were merged.

    “here we used a combination of methods and then merged the results.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductreasoning

    All genetic enrichment tests were conditioned on a background set of 16,423 genes with above-threshold expression in DLPFC.

    “we conditioned all enrichment tests on the background set of 16,423 genes with above-threshold expression that we had included in differential expression analysis”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    In the mouse haloperidol experiment, all experimental procedures were randomized to minimize batch artifacts, including assignment to treatment, home cage, dissection order, RNA extraction, and assay batch.

    “All experimental procedures were randomized to minimize batch artifacts, including assignment of mice to receive haloperidol (HAL) or placebo (PLA), home cage, order of dissection, RNA extraction, and assay batch.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductown data

    Differential expression and eQTL analyses in the HBCC cohort adjusted for diagnosis, age of death, sex, PMI, pH, RIN, clustered processing batch, and ancestry markers.

    “The following covariates were used in the differential expression (and eQTL) analysis: Dx, Age of death, sex, PMI, pH, RIN, clustered processing batch, and ancestry markers.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductcitation

    Quality control and analysis for all data types conformed to those developed in the authors' prior publications.

    “Quality control and analysis for all data types conformed to those developed in our prior publications19.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [19] Kim, Y. et al. A meta-analysis of gene expression quantitative trait loci in brain. Transl. Psychiatry 4, e459 (2014). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    For co-expression analysis, 5 outlier samples were removed, leaving a final cohort of 278 control samples and 254 schizophrenia cases.

    “we first removed 5 samples as outliers based on IAC analysis, specifically those more than 4 standard deviations from the mean), leaving a final cohort for co-expression analysis consisting of 278 control samples and 254 cases with schizophrenia.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Rare copy number variants and more than 100 common variants have been conclusively identified as genetic risk factors for schizophrenia.

    “only recently have specific genetic risk factors been conclusively identified, including rare copy number variants2 and >100 common variants3”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [2] Kirov, G. CNVs in neuropsychiatric disorders. Hum. Mol. Genet. 24, R45–R49 (2015). source

      Not checked in the free run.

    • cites [3] Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014). source

      Not checked in the free run.

  • May combine two claims.

    Premisereasoning

    Results of prior gene expression studies are often inconsistent and few findings have been replicated.

    “Results are often inconsistent and there are few replicated findings.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Available data implicate synaptic components, including calcium channel subunits and post-synaptic elements, in schizophrenia.

    “The available data are incomplete but implicate synaptic components, including calcium channel subunits and post-synaptic elements5–7.”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [5] Purcell, S.M. et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506, 185–190 (2014). source

      Not checked in the free run.

    • cites [6] Walsh, T. et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320, 539–543 (2008). source

      Not checked in the free run.

    • cites [7] Fromer, M. et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 506, 179–184 (2014). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Fifty-five cases with affective disorder were included to increase power to detect eQTLs.

    “Fifty-five cases with affective disorder were included to increase power to detect eQTLs.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductown data

    The median number of paired-end reads per sample was 41.6 million, with low numbers of rRNA reads.

    “The median number of paired end reads per sample was 41.6 million, with low numbers of rRNA reads (Supplementary Fig. 2).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Study design and conductown data

    Covariates for RIN, library batch, institution, diagnosis, age of death, genetic ancestry, PMI, and sex explained 0.42 of the average variance of gene expression and were used to adjust the data.

    “Covariates for RIN, library batch, institution (brain bank), diagnosis, age of death, genetic ancestry, PMI, and sex together explained a substantial fraction (0.42) of the average variance of gene expression, and were thus employed to adjust the data for all analyses.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductown data

    Multiple randomization steps and centralized DNA and RNA isolation and library preparation were used to control batch effects.

    “To control for batch effects, multiple randomization steps were introduced and DNA and RNA isolation and library preparation were performed at one site (Supplementary Fig. 1A).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    More than 50 gene expression studies of schizophrenia cases and controls have been reported, often with overlapping samples and mostly modest scale; prior RNA sequencing studies evaluated only 5-31 cases.

    “More than 50 gene expression studies of SCZ cases and controls have been reported, often of overlapping samples and mostly of modest scale (prior RNA sequencing studies evaluated only 5–31 cases, Supplementary data file 1).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Supplementary data file 1

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    CLCN3, SNAP91, and TSNARE1 are direct synaptic components, and CNTN4 and FURIN play roles in neurodevelopment.

    “CLCN3, SNAP91, and TSNARE1 are direct synaptic components, and CNTN4 and FURIN play roles in neurodevelopment.”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites [27] Guzman, R.E., Alekov, A.K., Filippov, M., Hegermann, J. & Fahlke, C. Involvement of ClC-3 chloride/proton exchangers in controlling glutamatergic synaptic strength in cultured hippocampal neurons. Front. Cell. Neurosci. 8, 143 (2014). source

      Not checked in the free run.

    • cites [28] Shimoda, Y. & Watanabe, K. Contactins: emerging key roles in the development and function of the nervous system. Cell Adh Migr 3, 64–70 (2009). source

      Not checked in the free run.

    • cites [29] Kaneko-Goto, T., Yoshihara, S., Miyazaki, H. & Yoshihara, Y. BIG-2 mediates olfactory axon convergence to target glomeruli. Neuron 57, 834–846 (2008). source

      Not checked in the free run.

  • May combine two claims.

    Interpretationcitation

    For a gene whose differential expression is mainly determined by case-control allele frequency difference at an eQTL SNP, the expected fold change is on the order of the allele frequency differences (~1-2%), matching the CommonMind Consortium data.

    “For that gene, the expected magnitude of differential expression fold change will be on the order of the allele frequency differences seen in the recent large Psychiatric Genomic Consortium SCZ genetic association study (~1–2%)3, precisely what is observed in the CMC data.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [3] Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    IGF2 can rescue neurogenesis and cognitive deficits in certain mouse models of schizophrenia.

    “can rescue neurogenesis and cognitive deficits in certain mouse models of schizophrenia44”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [44] Ouchi, Y. et al. Reduced adult hippocampal neurogenesis and working memory deficits in the Dgcr8-deficient mouse model of 22q11.2 deletion-associated schizophrenia can be rescued by IGF2. J. Neurosci. 33, 9408–9419 (2013). source

      Not checked in the free run.

  • May combine two claims.

    Interpretationown data

    Overall results point to the M2c module of about 1,400 genes with synaptic transmission functions being enriched for differential expression, overlapping schizophrenia genetic signal, and with some genes having less dense co-expression in schizophrenia cases.

    “Overall, our results point to the M2c module of ~1400 genes that possess functions related to synaptic transmission as being enriched for differential expression, overlapping SCZ genetic signal, and with some genes having less dense co-expression in SCZ cases.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    The differential expression observed is smaller than earlier studies but consistent with plausible models for average differential gene expression and polygenic inheritance of schizophrenia.

    “The differential expression observed here is smaller than that reported in earlier studies (Supplementary data file 1), but it is consistent with plausible models for average differential gene expression and the polygenic inheritance of SCZ”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    Detected replicable differences in gene expression in schizophrenia point to subtle but broad disruption in transcription, consistent with the polygenic nature of genetic risk underlying schizophrenia.

    “We also detected replicable differences in gene expression in SCZ that point to subtle but broad disruption in transcription, which is consistent with the polygenic nature of genetic risk underlying SCZ.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    Experimental manipulation of three of the single-gene loci genes had an impact on neuroanatomical and developmental attributes in model systems, making these genes excellent candidates for further biological investigation.

    “Experimental manipulation of three of these genes had an impact on neuroanatomical and developmental attributes in model systems, making these genes excellent candidates for further biological investigation.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    The order of extraction for schizophrenia-affected and control samples was randomized with respect to brain bank, diagnosis, and other sample characteristics.

    “The order of extraction for SCZ-affected and control samples was assigned randomly with respect to brain bank, diagnosis, and all other sample characteristics.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Pitt matched case-control pairs were always processed in the same RNA extraction batch.

    “Samples were processed in batches of 12, and the Pitt matched case/control pairs were always processed in the same batch.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Interpretationown data

    In situ hybridization data suggest that genes identified by differential expression analysis display various degrees of cell-type specificity, which could affect estimated fold changes.

    “Available in situ hybridization data from DLPFC suggest that genes identified by DE analysis display various degrees of cell-type specificity, which could affect the estimated fold changes (Supplementary Fig. 10).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationown data

    The analyses find that genes highlighted by the schizophrenia case-control contrast do not largely trace their differential expression to antipsychotic medications, although they suggest a mechanism for the efficacy of these drugs.

    “Thus, our analyses find that genes highlighted by the contrast of SCZ cases versus control subjects do not largely trace their differential expression to antipsychotic medications, although intriguingly they do suggest a mechanism for the efficacy of these drugs46.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [46] Carboni, L. & Domenici, E. Proteome effects of antipsychotic drugs: learning from preclinical models. Proteomics Clin. Appl. 10, 430–441 (2016). source

      Not checked in the free run.

  • May combine two claims.

    Interpretationown data

    Body length and somitic structures were similar across embryos, suggesting the observations were unlikely due to gross developmental delay.

    “Body length and somitic structures were similar across all embryos, suggesting that our observations were unlikely due to gross developmental delay.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    Modeling can explain the difference between earlier studies and CommonMind Consortium results; larger differential expression in smaller earlier studies is consistent with Winner's Curse or false positives.

    “Beyond case-control difference in allele frequency, our modeling can also explain the difference between earlier studies and CMC results (Supplementary Fig. 9); because earlier studies tend to be far smaller in sample size, their larger differential expression is consistent with either the well-known “Winner’s Curse”41 or false positives that may occur in smaller samples.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [41] Xiao, R. & Boehnke, M. Quantifying and correcting for the winner's curse in genetic association studies. Genet. Epidemiol. 33, 453–462 (2009). source

      Not checked in the free run.

  • May combine two claims.

    Interpretationnone given

    The dysregulation of M2c in schizophrenia is not due to medication effect or clinical and technical confounds.

    “The dysregulation of M2c in SCZ is not due to medication effect or clinical and technical confounds.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning

    Five ancestry vectors were added to the eQTL regression to adjust for population differences in SNP allele frequencies.

    “The 5 ancestry vectors were included instead in the eQTL model to control for ancestry differences in SNP allele frequencies.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Processing order was re-randomized before ribosomal RNA depletion.

    “Processing order was re-randomized prior to ribosomal RNA (rRNA) depletion, and samples were processed in batches of 8.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    In 85% of analyzed isoforms, the correlation across samples between unique reads per isoform and isoform-level CPM exceeded 0.2.

    “For 85% of the analyzed isoforms, the correlation across samples between the number of unique reads per isoform, arguably, the most direct measure of relative isoform abundance from RNA-seq, and the isoform-level CPM was above 0.2.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductreasoning

    All overlap enrichment tests used a background of 16,423 genes that passed the expression threshold.

    “we conditioned all enrichment tests on the background set of 16,423 genes with above-threshold expression that we had included in differential expression analysis”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Laboratory hiPSC and NPC cultures underwent monthly MycoAlert testing for mycoplasma.

    “All hiPSC and NPCs in the laboratory are tested monthly using MycoAlert (Lonza) to ensure they remain mycoplasma free.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductown data

    RNA-seq outliers were identified by consensus between two independent analysis groups, and the 10 samples flagged by both were removed.

    “The results from analysis (i) and (ii), were compared for consensus. In total, 10 samples were identified as outliers by both groups and these were eliminated from all subsequent analyses.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Study design and conductown data

    The RNA-seq versus qPCR comparison accounts for possible differences in pathological sampling of brain region and variability in RNA extraction.

    “Therefore our results also account for possible differences in pathological sampling of brain region and variability in RNA extraction.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Interpretationnone given

    The CMC eQTL data are substantially larger than existing brain eQTL datasets, which were therefore more limited in power for eQTL discovery.

    “Then, because the data herein are substantially larger than existing brain eQTL datasets that were therefore more limited in power for eQTL discovery, we focused on testing the sensitivity of our eQTL towards recapitulating publicly available eQTL.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationown data

    The lower correlation cannot be attributed to age alone.

    “It is important to note, however, that the effect of age is not the only possible explanation for a lower correlation”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductown data

    DNA and RNA data were verified to come from the same individual by comparing SNP calls from RNA-seq and genotyping.

    “We ensured DNA and RNA data were from a single individual by making SNP calls from RNA-seq results using samtools and bcftools 0.1.19, using the author-recommended protocol, which includes the “Bayesian inference” option.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Fifteen samples failed the sequencing criteria and were discarded.

    “In the end, a total of 15 samples did not meet these sequencing criteria (see “Sample QC” below) and were discarded.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Premisereasoning

    Because RNA-seq avoids microarray hybridization problems like background noise, it has greater dynamic range and can measure low-abundance transcripts.

    “Given the broader dynamic range of RNASeq and its ability to detect low abundance transcripts – because it does not suffer from hybridization-based limitations associated with microarray such as background noise – we would expect to see large fold-changes, if they existed, even for genes displaying low expression; or expression and differential expression restricted to a specific subset of cells.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductown data

    Pitt specimens were provided as matched case-control pairs, perfectly matched for sex and closely matched for age and race.

    “Specimens from Pitt were provided as matched case/control pairs. These were perfectly matched for sex, and as closely as possible for age (73% of pairs were matched within 5 years, and 95% within 10 years) and race (71% of pairs were matched for race).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductown data

    The final covariate model included 12 sample variables and 1 experiment variable, accounted for 23 degrees of freedom, and yielded an average r2 of 0.42.

    “The final model, which we call “the covariate model”, included 12 sample variables (Dx [3], Institution [3], Sex [2], AOD, PMI, RIN, RIN2, and 5 ancestry vectors) and 1 experiment variable (clustered LIB [9]), where the number of levels for factor variables is noted here in square brackets. Counting the intercept term, this model accounted for 23 df and yielded an average r2 of 0.42”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Members of each Pitt case-control pair were always processed together for RNA-seq.

    “Members of a pair were always processed together for RNA-seq.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Subsequent studies used only hiPSC lines with normal karyotypes.

    “Karyotyping analysis was performed by Wicell Cytogenetics (Madison WI); only karyotypically normal lines were used for subsequent studies.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Genotyping plates included an internal HapMap control in two unique locations.

    “Samples for genotyping were aliquoted onto 96 well plates, where each plate had an internal control from the HapMap project (NA12878 - Coriell Institute) in two unique locations.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    In the mouse haloperidol study, randomization was used across procedures to reduce batch artifacts, covering drug assignment, home cage, dissection order, RNA extraction, and assay batch.

    “All experimental procedures were randomized to minimize batch artifacts, including assignment of mice to receive haloperidol (HAL) or placebo (PLA), home cage, order of dissection, RNA extraction, and assay batch.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductown data

    The HBCC differential expression analysis adjusted for diagnosis, age at death, sex, postmortem interval, pH, RNA integrity number, processing batch, and ancestry markers.

    “The following covariates were used in the differential expression (and eQTL) analysis: Dx, Age of death, sex, PMI, pH, RIN, clustered processing batch, and ancestry markers.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    The correspondence between qPCR and RNA-seq expression estimates is notable because the two methods differ and the samples were drawn independently for the two experiments.

    “The correspondence between estimates is notable because of the different measurement methodologies and because, while the samples came from the same subject and brain region, they were drawn independently for the qPCR and RNA-seq experiments.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductown data

    Each zebrafish experiment was run twice, and the results were pooled.

    “All experiments were replicated twice and aggregate data was compiled.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductown data

    Initial genotype quality control removed markers with zero alternate alleles, call rate at or below 0.98, Hardy-Weinberg P below 5e-5, and individuals with call rate below 0.90.

    “Initial QC was preformed using PLINK 57 to remove markers with: zero alternate alleles, genotyping call rate ≤ 0.98, Hardy-Weinberg P value < 5 × 10−5, and individuals with genotyping call rate < 0.90.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning

    Affective disorder cases and matched controls from Pitt were randomized among the remaining schizophrenia and control samples still queued for extraction.

    “Because the affective disorder cases (AFF) and matched controls from Pitt were not available until after the processing of the SCZ and controls was underway, these samples were randomized among the remaining 132 SCZ and control samples still queued for extraction at that time.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    All NPC experiments used passage-matched cells at passages 9 through 12.

    “NPC experiments were conducted on passage-matched populations, between passages 9 and 12.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationown data

    The haloperidol result-enrichment with opposite-direction concordance-may fit a model where antipsychotics act on these genes in a direction opposite to disease causation.

    “For haloperidol, the enrichment of significance but depletion of concordance is perhaps consistent with a scenario in which such antipsychotic drugs target these genes and affect them in the opposite direction of what etiologically occurs in the course of disease (hence their efficacy).”
    Quote in the paperNot a substantial claim
    • The authors state this as an assumption: The directional-concordance hypergeometric test assumes that drug-responsive up- and down-regulated genes were drawn at random from genes up- or down-regulated in the CMC SCZ differential expression tests.
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductnone given

    Samples were retained for downstream analysis only if they had at least 50 million mapped reads and less than 5% rRNA-aligned reads.

    “Samples with a minimum of 50 million mapped reads (~25 million paired end reads) and less than 5% rRNA-aligned reads were retained for downstream analysis.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Of 633 samples sent for sequencing, 15 were removed because they had fewer than 50 million total reads or more than 5% rRNA-aligned reads after two attempts.

    “Of the 633 samples sent for sequencing (those with RIN ≥ 5.5), 15 samples were removed because they yielded < 50 million total reads (~25 million paired end reads) or had > 5% of reads aligning to rRNA, based on two attempts to produce quality sequence”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Genotyping quality control removed two samples from the analysis.

    “This removed 2 samples from the analysis.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductown data

    After quality control, 668 individuals genotyped at 767,368 markers were used for imputation.

    “After QC, 668 individuals genotyped at 767,368 markers were used for imputation.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Fifty-one samples with RNA integrity number below 5.5 were excluded from the study.

    “51 samples with RIN < 5.5 were excluded from the study (see Sample QC below).”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductnone given

    Samples were excluded if RNA integrity number was below 5.5 or if genetic information was inconsistent with subject descriptors such as sex.

    “Samples were excluded if RIN < 5.5 or genetic information from the sample was inconsistent with subject descriptors such as sex.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    After preprocessing and quality control, the HBCC DLPFC microarray cohort contained 131 SCZ and 176 control samples.

    “there remained 131 SCZ and 176 control samples”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductreasoning

    HBCC data were processed with a pipeline intended to match the CMC RNA-seq workflow.

    “To maximize comparability with the CMC data, we designed an analysis pipeline analogous to that which we used for the CMC RNA-seq processing.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductown data

    The full quality-control process yielded 592 high-quality samples for analysis: 258 schizophrenia cases, 279 controls, and 55 affective disorder cases.

    “The entire QC process yielded 592 high-quality samples for analysis (258 SCZ, 279 control individuals, and 55 AFF [47 bipolar disorder, 6 major depressive disorder, and 2 mood disorder, unspecified]), with demographic breakdown of the cases and controls as described in Supplementary Table 1.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    For RNA-seq, GOSeq is advantageous because it models the detection bias affecting long and highly expressed transcripts.

    “Compared to the hypergeometric and Fisher’s tests, GOSeq has an advantage for RNA-seq data in that it explicitly accounts for the detection bias of long and highly expressed transcripts.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [111] Young, M.D., Wakefield, M.J., Smyth, G.K. & Oshlack, A. Gene ontology analysis for RNA-seq: accounting for selection bias. Genome Biol. 11, R14 (2010). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Co-expression analysis excluded five outlier samples identified by IAC as more than four standard deviations from the mean, leaving 278 controls and 254 schizophrenia cases.

    “we first removed 5 samples as outliers based on IAC analysis, specifically those more than 4 standard deviations from the mean), leaving a final cohort for co-expression analysis consisting of 278 control samples and 254 cases with schizophrenia.”
    Quote in the paperNot a substantial claim
222 of 222
  • The authors state this as an assumption.

    How schizophrenia-associated genetic variants confer liability is uncertain.

    “yet how these variants confer liability is uncertain”
  • The paper relies on this without support.

    Dorsolateral prefrontal cortex gene expression is a valid tissue for understanding the molecular etiology of schizophrenia.

    “The roots of these deficits lie in cortical function and integration, at least in part tracing to the DLPFC.”
    “Here we have used gene expression derived from this tissue to understand how genetic liability is related to the molecular etiology of SCZ.”
  • The paper relies on this without support.

    Case-control differences in allele frequencies for schizophrenia risk variants are small.

    “Yet the magnitude of differential expression will be determined largely by case-control differences in allele frequencies, which we know are small.”
  • The authors state this as an assumption.

    When a risk gene's expression is altered by genetic variation, the same SNPs should show genetic association with disease.

    “Its underlying principle is that genetic-driven changes in expression levels of risk genes (discovered as eSNPs) should ultimately also manifest as genetic association of those same SNPs with disease (GWAS SNPs).”
  • The authors state this as an assumption.

    If a gene's expression changes mediate disease risk, then its cis- and trans-eQTLs should also associate with the disease.

    “Specifically, we expect that cis-eQTL and trans-eQTL for a risk gene should be associated with disease (if risk is mediated by expression changes of that gene); note that the converse need not be true (since not all associated SNPs need be related to the function of any single disease gene).”
  • The paper relies on this without support.

    For most SNPs without clear schizophrenia association, selecting the major or minor allele is essentially random and unbiased.

    “Still, for most SNPs in the genome, those not clearly associated with SCZ, the choice of major or minor allele is essentially random and unbiased.”
  • The paper relies on this without support.

    The CMC cases carry an aggregate common polygenic schizophrenia risk burden.

    “Since the CMC cases bear an aggregate common polygenic schizophrenia risk burden, we subsequently performed an independent controls-only analysis”
  • The authors state this as an assumption.

    The directional-concordance hypergeometric test assumes that drug-responsive up- and down-regulated genes were drawn at random from genes up- or down-regulated in the CMC SCZ differential expression tests.

    “this was tested using a hypergeometric test whose null hypothesis assumes that up- and down-regulated drug-mediated genes were randomly sampled from genes either up- or down-regulated (at any P value) in the CMC SCZ differential expression tests.”
8 of 8

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Initial brain-specific functional genomics work provided greater insight but could be enhanced with larger sample sizes.

    “Initial work focusing on brain-specific functional genomics has provided greater insight but could be enhanced with larger sample sizes (11, 12).”
  • This estimate identified substantially more eQTLs and associated eGenes than previous studies, reflecting the large sample size.

    “This estimate identified substantially more eQTLs and associated eGenes than previous studies, reflecting our large sample size (8, 11, 21).”
  • The schizophrenia genes represent an increase from the 22 genes reported in an earlier QTL study and a larger number than can be linked by genomic proximity (176).

    “Overall, the SCZ genes represent an increase from the 22 genes reported in an earlier QTL study and a larger number than can be linked simply by genomic proximity (176) (Fig. 6A) (11, 47).”
  • DGE effect sizes were concordant with previous RNA-seq studies of individual disorders.

    “and with previous RNA-Seq studies of individual disorders (ASD: ⍴=0.96, ref (19); SCZ ⍴=0.78, ref (2); SCZ ⍴=0.80, ref (24); BD ⍴=0.85, ref (1); Spearman ⍴ of log2FC, all P’s<10−16).”
  • The study combined RNA-seq data from eight studies through a uniform processing pipeline, yielding 2188 samples that passed QC, from 1695 unique subjects, including 279 technical replicates.

    “Data was generated across eight studies (2, 19, 20), uniformly processed, and combined through a consolidated genomic data processing pipeline ((21); Fig S1), yielding a total of 2188 samples passing quality control (QC) for this analysis, representing frontal and temporal cerebral cortex from 1695 unique subjects across the lifespan, including 279 technical replicates (Fig S2).”

Statistics recomputed

Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.

  • Consistentz = -3.02reported p = .003 · recomputed p = .003

    “(Z = −3.02, p = .003”

1 of 1

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

  • Expected count of P values below 0.05 is overstated

    Minor

    For 537 samples, a 0.05 chance per sample gives an expected count of 26.85, or about 27, rather than 29.

    Reported 29 · recomputed 26.85

1 of 1

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Fromer, M., Roussos, P., Sieberts, S. K., Johnson, J. S., Kavanagh, D. H., Perumal, T. M., Ruderfer, D. M., Oh, E. C., Topol, A., Shah, H. R., Klei, L. L., Kramer, R., Pinto, D., Gümüş, Z. H., Cicek, A. E., Dang, K. K., Browne, A., Lu, C., Xie, L., Readhead, B., Stahl, E. A., Xiao, J., Parvizi, M., Hamamsy, T., Fullard, J. F., Wang, Y.-C., Mahajan, M. C., Derry, J. M. J., Dudley, J. T., Hemby, S. E., Logsdon, B. A., Talbot, K., Raj, T., Bennett, D. A., De Jager, P. L., Zhu, J., Zhang, B., Sullivan, P. F., Chess, A., Purcell, S. M., Shinobu, L. A., Mangravite, L. M., Toyoshiba, H., Gur, R. E., Hahn, C.-G., Lewis, D. A., Haroutunian, V., Peters, M. A., Lipska, B. K., Buxbaum, J. D., Schadt, E. E., Hirai, K., Roeder, K., Brennand, K. J., Katsanis, N., Domenici, E., Devlin, B., & Sklar, P.
Affiliations
  • Icahn School of Medicine at Mount Sinai (US)
  • Sage Bionetworks (US)
  • Duke University (US)
  • University of Pittsburgh (US)
  • National Institutes of Health (US)
  • Carnegie Mellon University (US)
  • High Point University (US)
  • Cedars-Sinai Medical Center (US)
  • Broad Institute (US)
  • Rush University Medical Center (US)
  • University of North Carolina at Chapel Hill (US)
  • Takeda (Japan) (JP)
  • University of Pennsylvania (US)
  • University of Trento (IT)
Corresponding author
Sklar, Pamela
Venue
Nature Neuroscience
Published
2016-09-26
Volume
19
Issue
11
Pages
1442-1453
ISSN
  • 1097-6256 (ISSN-L)
  • 1546-1726
OpenAlex
W2526546796
Cited by
1,091
References
155
Citations by year
2026: 58 · 2025: 75 · 2024: 99 · 2023: 105 · 2022: 128 · 2021: 141 · 2020: 146 · 2019: 146 · 2018: 110 · 2017: 70 · 2016: 11
FWCI
98.53
Type
journal article
Language
en
Open access
Locations
  • Nature Neuroscience (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • Iris (University of Trento) (submittedVersion, other-oa)
Funders
  • U.S. Department of Veterans Affairs (I01BX002395)
  • National Institutes of Health (1s10od018522-01)
  • National Institute on Aging (R01AG017917, R01AG036836, U01AG046152, R01AG015819, P30AG010161, RF1AG015819, R01AG050986)
  • National Institute of Mental Health (P50MH084053, P50MH096891, HHSN271201300031C, U01MH096296, R01MH093725, P50MH066392, R01MH109706, R21MH105881, R01MH109677, R01MH075916, R01MH085542, R37MH057881, R01MH097276, R01MH101454, R01MH074313, R01MH095034, R01MH110555, P50MH094268, T32MH087004)
  • National Human Genome Research Institute (U01HG008451)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
schizophrenia, polygenic risk, gene expression, dorsolateral prefrontal cortex, furin, CNTN4, CLCN3, brain development, zebrafish, gene co-expression network, genetic susceptibility
MeSH terms
Brain, Female, Gene Expression Regulation, Humans, Male, Risk, Schizophrenia, Genetic Predisposition to Disease, Multifactorial Inheritance, Polymorphism, Single Nucleotide, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review